showed a trendP = 0.098
YAC128 mice treated with 50 μg HTT ASO showed a trend toward increased plasma NfL compared to PBS at each time point over the 3-month interval, which was highest at 1-month post-treatment ( P = 0.098).
YAC128 mice treated with 50 μg HTT ASO showed a trend toward increased plasma NfL compared to PBS at each time point over the 3-month interval, which was highest at 1-month post-treatment ( P = 0.098).
A strong trend towards a significant treatment effect on plasma NfL concentrations was observed over the 6-month interval in response to 50 μg HTT ASO treatment initiated at 8 months of age (Fig.